Financial News
All News about Alnylam Pharmaceuticals
![](https://mms.businesswire.com/media/20220609005222/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_14852.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_14845.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220602005790/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20220602005537/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20220524005288/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6694.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220523005342/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20220504005116/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/05/02/price_targets.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_4085.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_9601.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/28/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220428005131/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_3807.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_8498.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/04/24/biotech2.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_3453.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220414005091/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20220405006017/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20220404005293/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/pexels-pavel-danilyuk-8442380.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220322005164/en/1161817/5/Alnylam_Corporate_Logo.jpg)
Alnylam to Webcast Presentation at Stifel 2022 CNS Days
March 22, 2022
Via Business Wire
![](https://cdn.pixabay.com/photo/2015/01/15/16/17/hands-600497_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/covid-19-vaccine-image_by_x3_from_pixabay_46.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_3889.png?width=1200&height=800&fit=crop)
Alnylam Hits Pfizer, Moderna With Patent Infringement Suits
March 17, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.